AI merges patient records and pathogen DNA
By combining complete electronic health records with bacterial genomes, a new AI platform predicts sepsis outcomes far better than traditional clinical scores.
August 7, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🧬 Genetics.
Standardizing Seventy Years of Messy Medical Data
The federal government is trying to force seven decades of incompatible medical research into a single format that artificial intelligence can actually understand.
August 1, 2026
AI learns human genetics from medical records
An AI trained only on medical records managed to map the genetic drivers of human disease.
July 30, 2026
NeoGx: Machine-Recommended Rapid Genome Sequencing for Neonates
An algorithm trained on electronic health records can flag critically ill newborns who need rapid gene sequencing weeks faster than human doctors alone.
July 28, 2026
Circulating protein profiling identifies prognostic biomarkers in amyotrophic lateral Sclerosis
Measuring a single protein has been the gold standard for tracking ALS, but a new multi-protein signature suggests we have been missing the bigger biological picture.
July 26, 2026
Nine blood proteins predict ALS survival rates
A new nine-protein blood signature outperforms traditional clinical models and single-marker tests in predicting how fast ALS progresses.
July 23, 2026
AI adapts genetic risk scores for diverse ancestries
A new deep learning tool bypasses the need for massive non-European genetic trials by adapting existing risk models to diverse populations.
July 16, 2026
AI Tool Predicts Cancer Survival From Single Cells
Averaging tumor data has long blinded oncologists to the specific, high-risk cells that drive patient mortality.
July 14, 2026
Matching blood by DNA, not just type
A mismatch between the genetic makeup of blood donors and recipients is driving a silent crisis in sickle cell care.
July 10, 2026
Digital Twins Solve Rare Disease Trial Dilemma
Using virtual clones to simulate disease progression could finally solve the recruitment bottleneck that stalls rare disease drug development.
July 5, 2026